SEC Info - Tetraphase Pharmaceuticals Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-35837

Tetraphase Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

480 Arsenal Way

Watertown, Massachusetts 02472

(617) 715-3600

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, Par Value $0.001 Per Share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:



		Rule 12g-4(a)(1)	☒
		Rule 12g-4(a)(2)	☐
		Rule 12h-3(b)(1)(i)	☒
		Rule 12h-3(b)(1)(ii)	☐
		Rule 15d-6	☐
		Rule 15d-22(b)	☐

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, Tetraphase Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.



			TETRAPHASE PHARMACEUTICALS, INC.

Date:	August 7, 2020	By:	/s/ *Larry Edwards*
			Larry Edwards
			President and Chief Executive Officer

This ‘15-12B’ Filing	Date	Other Filings

Filed on / Effective on:	8/31/20	EFFECT
	8/7/20	3
		List all Filings

Tetraphase Pharmaceuticals Inc. – ‘15-12B’ on 8/31/20

On: Monday, 8/31/20, at 3:19pm ET · Effective: 8/31/20 · Accession #: 1373707-20-39 · File #: 1-35837

Certification of a Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34
Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Tetraphase Pharmaceuticals Inc. – ‘15-12B’ on 8/31/20

On: Monday, 8/31/20, at 3:19pm ET · Effective: 8/31/20 · Accession #: 1373707-20-39 · File #: 1-35837

Certification of a Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Certification of a Termination of Registration of a Class of Securities — Form 15 — Sect. 12(b) – SEA’34
Filing Table of Contents